Literature DB >> 8549384

Levofloxacin: penetration into sputum and once-daily treatment of respiratory tract infections.

Y Nakamori1, Y Miyashita, I Nakatani, K Nakata.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8549384     DOI： 10.2165/00003495-199500492-00120

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  2 in total

1.  In vitro activity of DR-3355, an optically active ofloxacin.

Authors:  T Une; T Fujimoto; K Sato; Y Osada
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

2.  [Laboratory and clinical studies on levofloxacin].

Authors:  K Tanaka; M Iwamoto; S Maesaki; H Koga; S Kohno; K Hara; K Sugawara; M Kaku; S Kusano; O Sakito
Journal:  Jpn J Antibiot       Date:  1992-05
  2 in total
  2 in total

1.  The new fluoroquinolones: A critical review.

Authors:  G G Zhanel; A Walkty; L Vercaigne; J A Karlowsky; J Embil; A S Gin; D J Hoban
Journal:  Can J Infect Dis       Date:  1999-05

2.  Levofloxacin pharmacokinetics in adult cystic fibrosis.

Authors:  Carlton K K Lee; Michael P Boyle; Marie Diener-West; Lois Brass-Ernst; Michelle Noschese; Pamela L Zeitlin
Journal:  Chest       Date:  2007-03       Impact factor: 9.410
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.